Frequency of cells expressing CD44, a Head and Neck cancer stem cell marker: Correlation with tumor aggressiveness

We previously identified by flow cytometry a Lineage‐CD44+ (Lin‐CD44+) subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma (HNSCC). We now correlate clinical and histologic factors with Lin‐CD44+ cell frequency.

[1]  M. Wong,et al.  Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma , 2010, Journal of oncology.

[2]  M. Wicha,et al.  Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase , 2010, Head & neck.

[3]  W. Mackillop,et al.  Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States , 2009, International journal of cancer.

[4]  O. Er,et al.  Cancer Stem Cells in Solid Tumors , 2009, Oncology Research and Treatment.

[5]  S. Morrison,et al.  Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.

[6]  R. Weinberg,et al.  Cancer stem cells: mirage or reality? , 2009, Nature Medicine.

[7]  G. Wong,et al.  CD44 variant isoforms in head and neck squamous cell carcinoma progression , 2009, The Laryngoscope.

[8]  Yi-Wei Chen,et al.  Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. , 2009, Biochemical and biophysical research communications.

[9]  Jeffrey M. Rosen,et al.  The Increasing Complexity of the Cancer Stem Cell Paradigm , 2009, Science.

[10]  B. Mack,et al.  CD44s and CD44v6 Expression in Head and Neck Epithelia , 2008, PloS one.

[11]  F. Esteban,et al.  Prognostic significance of p21WAF1/CIP1, p16INK4a and CD44s in tongue cancer. , 2007, Oncology reports.

[12]  Sylvia M Golas.  Trends in palatine tonsillar cancer incidence and mortality rates in the United States. , 2007, Community dentistry and oral epidemiology.

[13]  M. Kuo,et al.  Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[14]  G. Sherlock,et al.  The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.

[15]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[16]  J. Grandis,et al.  The role of CD44 in HNSCC , 2007, Cancer biology & therapy.

[17]  Artur Ferreira,et al.  Oral squamous cell carcinoma: review of prognostic and predictive factors. , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[18]  I. Mackenzie,et al.  Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. , 2005, Cancer research.

[19]  G. Qin,et al.  [Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma]. , 2005, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology.

[20]  F. Khuri,et al.  Prevention of head and neck cancer: current status and future prospects. , 2004, Current problems in cancer.

[21]  Laurie E Ailles,et al.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.

[22]  I. Doweck,et al.  Factors Predictive of Local Disease Control after Intra‐arterial Concomitant Chemoradiation (RADPLAT) , 2004, The Laryngoscope.

[23]  Michael F. Clarke,et al.  Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.

[24]  F. Esteban,et al.  Adhesion molecule CD44 as a prognostic factor in tongue cancer. , 2003, Anticancer research.

[25]  C. Ko,et al.  Has survival improved for nasopharyngeal carcinoma in the United States? , 2003, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[26]  J. Piffkó,et al.  Gains and losses of adhesion molecules (CD44, E‐cadherin, and β‐catenin) during oral carcinogenesis and tumour progression , 2002, The Journal of pathology.

[27]  F. Pezzetti,et al.  CD44 as Prognostic Factor in Oral and Oropharyngeal Squamous Cell Carcinoma , 2002, The Journal of craniofacial surgery.

[28]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[29]  M. Fujita,et al.  Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. , 2000, Oral oncology.

[30]  M. Masuda,et al.  Decreased CD44H expression in early‐stage tongue carcinoma associates with late nodal metastases following interstitial brachytherapy , 2000, Head & neck.

[31]  I. Weissman,et al.  AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Baretton,et al.  Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. , 1999, Oral oncology.

[33]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[34]  P. Lansdorp,et al.  Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. , 1997, Blood.

[35]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[36]  Mark Shackleton,et al.  Efficient tumour formation by single human melanoma cells , 2008 .

[37]  V. Kosma,et al.  CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. , 2007, Oral oncology.

[38]  P. Herrlich,et al.  CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.